Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: GLAXOSMITHKLINE, LLC
Awarding agency: Department of Homeland Security / Office of Procurement Operations
Funding agency: Department of Homeland Security / Office of the Chief Human Capital Officer
Period of performance: 2021-09-10 to 2023-09-12
Current total value of award: $516000
Description: ANTIVIRAL MEDICINE (ZANAMIVIR - RELENZA) FOR THE DHS ANTIVIRAL STOCKPILE